Evidence map›Paper›PMID 28832547›Full record

ArticleInternational journal of molecular sciences2017

Fabrication of Innovative Silk/Alginate Microcarriers for Mesenchymal Stem Cell Delivery and Tissue Regeneration.

Sara Perteghella, Elisa Martella, Laura de Girolamo, Carlotta Perucca Orfei, Michela Pierini, Valentina Fumagalli, Domenica Valeria Pintacuda, Theodora Chlapanidas, Marco Viganò, Silvio Faragò and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Silk fibroin scaffolds: A promising candidate for bone regeneration.Frontiers in bioengineering and biotechnology · 2022
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Silk fibroin/gelatin microcarriers as scaffolds for bone tissue engineering.Materials science & engineering. C, Materials for biological applications · 2020
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sara PerteghellaDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy. sara.perteghella@unipv.it.
Elisa MartellaDepartment of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Via Zamboni 33, 40126 Bologna, Italy. elisa.martella@isof.cnr.it.
Laura de GirolamoIRCCS Istituto Ortopedico Galeazzi, Via R. Galeazzi 4, 20161 Milan, Italy. laura.degirolamo@grupposandonato.it.
Carlotta Perucca OrfeiIRCCS Istituto Ortopedico Galeazzi, Via R. Galeazzi 4, 20161 Milan, Italy. carlotta.perucca@grupposandonato.it.
Michela PieriniDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy. michela.pierini@ior.it.
Valentina FumagalliDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy. valentina.fumagalli@unipv.it.
Domenica Valeria PintacudaDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy. valeria.pintacuda@unipv.it.
Theodora ChlapanidasDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy. theodora.chlapanidas@unipv.it.
Marco ViganòIRCCS Istituto Ortopedico Galeazzi, Via R. Galeazzi 4, 20161 Milan, Italy. marco.vigano@grupposandonato.it.
Silvio FaragòSilk Division, Innovhub, Stazioni Sperimentali per l'Industria, Via G. Colombo 83, 20133 Milan, Italy. silvio.farago@mi.camcom.it.
Maria Luisa TorreDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy. marina.torre@unipv.it.
Enrico LucarelliOsteoarticular Regeneration Laboratory, 3rd Orthopaedic and Traumatologic Clinic, Rizzoli Orthopaedic Institute, Via Giulio Cesare Pupilli 1, 40136 Bologna, Italy. enrico.lucarelli@ior.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to exploit silk fibroin's properties to develop innovative composite microcarriers for mesenchymal stem cell (MSCs) adhesion and proliferation. Alginate microcarriers were prepared, added to silk fibroin solution, and then treated with ethanol to induce silk conformational transition. Microcarriers were characterized for size distribution, coating stability and homogeneity. Finally, in vitro cytocompatibility and suitability as delivery systems for MSCs were investigated. Results indicated that our manufacturing process is consistent and reproducible: silk/alginate microcarriers were stable, with spherical geometry, about 400 μm in average diameter, and fibroin homogeneously coated the surface. MSCs were able to adhere rapidly onto the microcarrier surface and to cover the surface of the microcarrier within three days of culture; moreover, on this innovative 3D culture system, stem cells preserved their metabolic activity and their multi-lineage differentiation potential. In conclusion, silk/alginate microcarriers represent a suitable support for MSCs culture and expansion. Since it is able to preserve MSCs multipotency, the developed 3D system can be intended for cell delivery, for advanced therapy and regenerative medicine applications.

Indexed as

MicrospheresAdultAlginatesAnimalsBombyxCell AdhesionCell ProliferationCells, CulturedFemaleFibroinsGuided Tissue RegenerationHumansMesenchymal Stem CellsStem Cell TransplantationAlginatesFibroinsalginatemesenchymal stem cellsmicrocarriersmusculoskeletal tissuesregenerative medicinesilk fibroin

Identifiers

PMID28832547
PMCPMC5618478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.